Safeguarding Women from Chemical Abortion Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This bill, the Safeguarding Women from Chemical Abortion Act, aims to restrict the use of mifepristone, a drug used in medication abortion. It seeks to effectively revoke the FDA approval for mifepristone, establish a federal tort liability for harm caused by these drugs, and create a private right of action for individuals seeking compensation for injuries related to their use. The bill’s provisions are intended to limit access to medication abortion and provide a legal pathway for those who believe they have been harmed by its use.
Key provisions
- Revokes FDA approval for mifepristone, a key component of medication abortion.
- Establishes a federal tort liability for harm to women resulting from the use of mifepristone.
- Creates a private right of action allowing individuals to sue manufacturers of mifepristone for bodily injury or mental health harm.
- Defines ‘covered entity’ as a manufacturer of mifepristone.
- Defines ‘covered medication’ as mifepristone for termination of intrauterine pregnancy.
- Allows for compensatory and punitive damages in lawsuits.
- Sets a 90-day delay before the tort liability provisions take effect.
- Clarifies that the Act does not preempt state laws providing other remedies.
Who is affected
- Women seeking medication abortion
- Pharmaceutical manufacturers of mifepristone
- Healthcare providers administering medication abortion
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
8 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours